首页|期刊导航|癌症生物学与医学(英文版)|High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
Yuling Xiao Xin Hu Zhiming Shao Yizhou Jiang Wei Huang Jinxiu Shi Hang Zhang Yi Xiao Ying Wang Jing Zhang Qi Hua Pengchen Hu Xinyan Lyu Weihua Shou
癌症生物学与医学(英文版)2025,Vol.22Issue(7):854-870,17.
癌症生物学与医学(英文版)2025,Vol.22Issue(7):854-870,17.DOI:10.20892/j.issn.2095-3941.2025.0038
High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer
摘要
关键词
Triple-negative breast cancer/immunotherapy/non-invasive biomarkers/efficacy prediction/plasma proteomic profilingKey words
Triple-negative breast cancer/immunotherapy/non-invasive biomarkers/efficacy prediction/plasma proteomic profiling引用本文复制引用
Yuling Xiao,Xin Hu,Zhiming Shao,Yizhou Jiang,Wei Huang,Jinxiu Shi,Hang Zhang,Yi Xiao,Ying Wang,Jing Zhang,Qi Hua,Pengchen Hu,Xinyan Lyu,Weihua Shou..High-precision immune-related plasma proteomics profiling predicts response to immunotherapy in patients with triple-negative breast cancer[J].癌症生物学与医学(英文版),2025,22(7):854-870,17.基金项目
This work was supported by the National Key Research and Development Project of China(Grant No.2021YFF1201300 and 2021YFF1201302),the Shanghai Committee of Science and Technology(Grant No.24DX2800100),and the Institutional Projects of SIBPT(Grant No.YZ2024-07). (Grant No.2021YFF1201300 and 2021YFF1201302)